New CPA Economic Report Warns of China Shock 2.0 as China Exports Now Flood the World
CPA Calls for U.S. to Adopt a Managed Approach to Trade, Setting Limits on Global Imports Through Tariffs and Quotas in Strategic Sectors
CPA Supports New Trade Petitions Filed by U.S. Solar Manufacturers in Response to Recent Trade Violations from Indonesia, Laos, & India
In response to market manipulation driven by companies in Indonesia, Laos, and India, the petitions were filed by The Alliance for American Solar Manufacturing and Trade.
CPA Condemns Senate Gutting FEOC Excise Tax, Weakening of FEOC Prohibitions
The Senate’s decision to remove the FEOC Excise Tax and weaken FEOC restrictions is a blatant giveaway to the Chinese Communist Party’s solar industry.
Vote Alert: CPA Urges Senators to Reject Amendments to Strike, Weaken FEOC Excise Tax
Any Senator who supports an amendment to remove or weaken the FEOC Excise Tax is directly endorsing China’s solar industry—dominated by companies using slave labor, powered by coal, and compromised by severe cybersecurity risks.
CPA Supports FEOC Excise Tax in President Trump’s “One Big Beautiful Bill” to Strengthen U.S. Solar Industry and National Security
CPA strongly endorses the FEOC Excise Tax in the Senate reconciliation bill as a critical step in protecting America’s solar manufacturing industry from reliance on subsidized and compromised Chinese components.
CPA Warns Senate Bill Contains Dangerous “Loophole” Benefiting China’s Solar Industry
CPA warned that the Senate version of President Trump’s reconciliation bill—known as the One Big Beautiful Bill—contains a critical loophole in both the Section 48E investment tax credit and 45Y production tax credit in the Inflation Reduction Act (IRA), creating an unintended but dangerous giveaway to China’s solar industry.
CPA Praises President Trump’s Decision to Increase Aluminum and Steel Tariffs to 50%
The President’s tariff increase comes at a critical moment, reflecting a clear understanding of the ongoing threats faced by the U.S. aluminum and steel industry, particularly from heavily subsidized foreign competitors.
CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines
A smart policy like the ‘PILLS Act’ would prioritize domestic production of essential generics. It’s precisely the market signal needed to attract serious investment and rebuild the industry at home.
CPA Releases Comments on Section 232 Investigation of Domestic Trucking Sector
CPA’s submission documents how the domestic trucking sector underpins U.S. commerce, and that ensuring a domestic industrial base for producing these trucks is vital to military readiness and civil emergency response.
CPA Releases Comments on Section 232 Investigation of Pharmaceutical Imports
As the leading organization advocating for reshoring the generic drug industry, CPA’s submission documents how extreme overreliance on foreign pharmaceutical supplies—especially active pharmaceutical ingredients (APIs) and critical injectable drugs from China and India—poses an urgent threat to U.S. national security and patient safety.
